发明名称 5-PHENYL-PENTANOIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OF ASTHMA AND OTHER DISEASES.
摘要 <p>The present invention relates to C ompounds having the structure of Formula I: wherein n is an integer from 1 to 5; R<sub>1</sub> is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, alkoxy, aryloxy, alkenyloxy or alkynyloxy; R<sub>2</sub> is alkenyl, allcynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, NR<sub>4</sub>R<sub>5</sub>, -NHC(=Y)R<sub>4</sub>, - NHC(=Y)NR<sub>5</sub>R<sub>??</sub>, -NHC(=O)OR<sub>4</sub>, -NHSO<sub>2</sub>R<sub>4</sub>, C(=Y)NR<sub>4</sub>R<sub>5</sub>, C(=O)OR<sub>6</sub> [wherein Y is oxygen or sulphur], OR<sub>5</sub>, -O(C=O)NR<sub>4</sub>R<sub>5</sub>, O-acyl, S(O)<sub>m</sub>R<sub>4</sub>, -SO<sub>2</sub>N(R<sub>4</sub>)<sub>2</sub>, cyano, amidino or guanidino [wherein R<sub>4</sub> is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl and m is an integer 0-2; R<sub>5</sub> is hydrogen or R<sub>4</sub>; R<sub>x</sub> is R<sub>4</sub> or -SO<sub>2</sub>N(R<sub>4</sub>)<sub>2</sub> and R<sub>6</sub> is hydrogen, alkyl, cycloalkyl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl]; R<sub>3</sub> is hydrogen, fluorine, alkyl, cycloalkylalkyl or aralkyl; A is OH, OR<sub>4</sub>, -OC(=O)NR<sub>4</sub>R<sub>5</sub>, O-acyl, NH<sub>2</sub>, NR<sub>4</sub>R<sub>5</sub>, -NHC(=Y)R<sub>4</sub>, -NHC(=Y)NR<sub>5</sub>R<sub>x</sub>, - NHC(=O)OR<sub>4</sub>, -NHSO<sub>2</sub>R<sub>4</sub>, and to processes for the synthesis of the same. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterized by over-expression and over-activation of an matrix metalloproteinase, using the compounds.</p>
申请公布号 MX2007010185(A) 申请公布日期 2007.12.06
申请号 MX20070010185 申请日期 2006.02.21
申请人 RANBAXY LABORATORIES LIMITED. 发明人 VENKATA P. PALLE;VISWAJANANI JITENDRA SATTIGERI;MANOJ KUMAR KHERA;SREEDHARA RAO VOLETI;ABHIJIT RAY;SUNANDA G. DASTIDAR
分类号 C07D249/18;A61P11/06;C07D207/40;C07D209/12;C07D209/48;C07D211/88;C07D213/64;C07D237/32;C07D239/54;C07D239/96;C07D263/58;C07D265/28;C07D401/10;C07D403/10;C07D471/04 主分类号 C07D249/18
代理机构 代理人
主权项
地址